SURVIVAL AFTER ALLOGENOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) IS NOT INFLUENCED BY PRETRANSPLANT INTERFERON-ALPHA THERAPY
R. Hehlmann et al., SURVIVAL AFTER ALLOGENOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) IS NOT INFLUENCED BY PRETRANSPLANT INTERFERON-ALPHA THERAPY, British Journal of Haematology, 102(1), 1998, pp. 317-317